ClinicalTrials.gg
Drug

Atrasentan clinical trials

Also written ABT-627 and CHK-01.

studies test it
21
open now
3
in phase 3
10
first study started
2001

How each study uses Atrasentan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Atrasentan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
2 Apr 2025 · VANRAFIA · NDA 219208 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Atrasentan
16
atrasentan hydrochloride
8
Xinlay
2

Brand

vanrafia
1

Development codes

ABT-627
7
CHK-01
4
EXV811
1

Studies by the year they started

21 studies that test it; most in 2001 (5)

Studies that test Atrasentan, by start year
YearStudies
20015
20023
20032
20061
20112
20131
20151
20201
20211
20231
20263

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
10
Phase 3
10
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 7

Novartis Pharmaceuticals (5) · Abbott (5) · AbbVie (2) · AbbVie (prior sponsor, Abbott) (2) · Eastern Cooperative Oncology Group (1) · SWOG Cancer Research Network (1) · Massachusetts General Hospital (1) · Mayo Clinic (1)

Often tested with

Tested in the same studies.

Zoledronic Acid (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Atrasentan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 21

See all 21 studies that test Atrasentan →

Codes

What other systems call Atrasentan · ClinicalTrials.gg INT006813

  • MeSH (NLM) D000077868AtrasentanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) V6D7VK2215ATRASENTANConfirmed FDA, NLM, Wikidata
  • RxNorm 282355One source Wikidata
  • Wikidata Q125083atrasentanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61606AtrasentanOne source FDA
  • DrugBank DB06199One source Wikidata

Also registered as atrasentan hydrochloride (UNII E4G31X93ZA).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.